Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 1-11083 BOSTON SCIENTIFIC CORPORATION (Exact name of registrant as specified in its charter) Delaware 04-2695240 (State or other jurisdiction of incorporation or ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Boston Scientific (BSX) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.Boston Scientific is a member of the Medical sector. This group includes 1051 individual stocks and currently holds a Zacks Sector Rank of #4. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the in ...

The first-quarter reporting cycle is in full swing. Apparently, the MedTech companies (Zacks-defined Medical Products stocks) within the broader Medical sector have witnessed a marginal increase in earnings year over year.The sector players that have released their earnings so far showed market share gain within their base businesses through the months of the first quarter compared with the same period in 2023.However, ongoing macroeconomic headwinds in the form of supply chain disruption and labor shortage ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.Zacks Premium includes access to the Zacks Style Scores as well.What are the Zacks Style Scores?T ...

Boston Scientific Corporation (BSX) posted adjusted earnings per share (EPS) of 56 cents for the first quarter of 2024, up 19.1% from the year-ago figure. The figure beat the Zacks Consensus Estimate by 9.8% and also exceeded the company’s adjusted earnings per share guidance range of 50-52 cents per share.The quarter’s adjustments included certain amortization expenses, acquisition/divestitures-related net charges, and restructuring and restructuring-related charges, among others.Reported EPS for the first ...

Key TakeawaysBoston Scientific exceeded first-quarter profit and sales forecasts on demand for its cardiovascular devices.The results were lifted by regulatory approval and launch of its product to treat irregular heartbeats.The news sent shares of Boston Scientific to an all-time high. Shares of Boston Scientific (BSX) hit an all-time high Wednesday as the maker of medical equipment reported better-than-anticipated quarterly results and boosted its guidance on demand for its cardiovascular devices, includi ...

Boston Scientific Corporation (NYSE:BSX) Q1 2024 Earnings Conference Call April 24, 2024 8:00 AM ET Company Participants Jon Monson - Senior Vice President, Investor Relations Mike Mahoney - Chairman and Chief Executive Officer Dan Brennan - Executive Vice President and Chief Financial Officer Ken Stein - Chief Medical Officer Conference Call Participants Robbie Marcus - JPMorgan Larry Biegelsen - Wells Fargo Rick Wise - Stifel Joanne Wuensch - Citi Vijay Kumar - Evercore ISI Travis Steed - Bank of America ...

For the quarter ended March 2024, Boston Scientific (BSX) reported revenue of $3.86 billion, up 13.8% over the same period last year. EPS came in at $0.56, compared to $0.47 in the year-ago quarter.The reported revenue represents a surprise of +4.85% over the Zacks Consensus Estimate of $3.68 billion. With the consensus EPS estimate being $0.51, the EPS surprise was +9.80%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine t ...

Boston Scientific (BSX) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.47 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 9.80%. A quarter ago, it was expected that this medical device manufacturer would post earnings of $0.51 per share when it actually produced earnings of $0.55, delivering a surprise of 7.84%.Over the last four qua ...

Q1 2024 Highlights April 24, 2024 1 Q1 2024 Financial & Operational Highlights | April 24, 2024 Safe Harbor for Forward-Looking Statements and Use of Document Safe Harbor for forward-looking statements: This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward- looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "may," "i ...